Key result
Re-evaluation of serum lipid values increased the proportion of hypertensive patients classified into high or very high cardiovascular risk groups to 55.2%-62.6% across different cohorts.
Why the study?
Does the evaluation of dyslipidemia improve cardiovascular risk stratification in hypertensive patients?
Observational (n=1,817)
Yes
Does the evaluation of dyslipidemia improve cardiovascular risk stratification in hypertensive patients?
Evaluating serum lipid levels in hypertensive patients significantly increases the proportion identified as high or very high cardiovascular risk, allowing for more appropriate targeted treatment.
Answers are grounded in this paper and cite their sources.
May support lipid re-evaluation for refined risk stratification in hypertension; hypothesis-generating and requires prospective validation.
BACKGROUND: Hypertension, dyslipidemia, and other cardiovascular risk factors are linked epidemiologically, clinically, and metabolically. Intensive/Initial Cardiovascular Examination regarding Blood Pressure levels, Evaluation of Risk Groups (ICEBERG) study focuses on the effect of dyslipidemia on cardiovascular risk evaluation and association of lipid profile with other risk factors. PATIENTS AND METHODS: The ICEBERG study consisted of two sub-protocols: ICEBERG-1, conducted at 20 university hospitals (Referral Group) and ICEBERG-2, conducted at 197 primary healthcare centers (Primary Care Group). Sub-protocol had two patient profiles: patients previously diagnosed with essential hypertension and under medical treatment (Treated Group) and patients with systolic blood pressure ≥130 mmHg or diastolic blood pressure ≥85 mmHg, with no antihypertensive treatment for at least 3 months before inclusion (Untreated Group). Dyslipidemia was evaluated and cardiovascular risk stratification was performed according to ESC/ESH guidelines. RESULTS: More than half of the treated and untreated subjects were classified into high or very high cardiovascular risk groups. In a total of 1817 patients, the percentage of patients in "high" plus "very high" added risk groups increased to 55.2% in Treated Referral Group (p < 0.001), to 62.6% in Untreated Referral Group (p = 0.25) and to 60.7% in Untreated Primary Care Group (p < 0.001), by re-evaluation of patients' lipid values. CONCLUSIONS: Serum lipid levels are useful in stratifying hypertensive patients into cardiovascular risk groups more accurately, for appropriate antihypertensive treatment.
No takes yet. Share an insight, caveat, or question.
Giray Kabakçı (2008) conducted an observational in Hypertension and dyslipidemia (n=1,817). Re-evaluation of lipid values was evaluated on Percentage of patients in high plus very high added cardiovascular risk groups. Re-evaluation of serum lipid values increased the proportion of hypertensive patients classified into high or very high cardiovascular risk groups to 55.2%-62.6% across different cohorts.
Synapse has enriched 10 related papers. Consider them for comparative context: